CDKN2A and neoplasm: Besides, we also found that the compared with wild type, SCD5 expression was down-regulated in several oncogene/tumor suppression genes mutation type (Figure S5) such as KRAS (Kirsten Rat Sarcoma Viral Oncogene Homolog), BRAF (B-Raf proto-oncogene, serine/threonine kinase and CDKN2A (cyclin dependent kinase inhibitor 2A).